Medical Care
Global Modified Release Formulation Market Research Report 2025
- Nov 18, 25
- ID: 598710
- Pages: 91
- Figures: 95
- Views: 18
This report aims to provide a comprehensive presentation of the global market for Modified Release Formulation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Modified Release Formulation.
The Modified Release Formulation market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Modified Release Formulation market comprehensively. Regional market sizes, concerning products by Type, by Application, by Drugs Type and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Modified Release Formulation companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
AbbVie
Novartis
Recipharm
Alkermes
Bristol‑Myers Squibb
Boehringer Ingelheim
Bayer
SPH
Novo Nordisk
Sanofi-Aventis
Eli Lilly
Tonghua Dongbao
United Laboratory
Biocon
Torrent Pharma
Amphastar
Ganlee
GSK
Segment by Type
Tablet
Injection
Segment by Drugs Type
Brand Drugs
Generic Drugs
Segment by Disease
Central Nervous System Diseases
Cardiovascular Diseases
Diabetes
Cancer
Chronic Pain
Other
Segment by Application
Hospital
Retail Pharmacy
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Drugs Type etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Modified Release Formulation company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Modified Release Formulation market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Modified Release Formulation market comprehensively. Regional market sizes, concerning products by Type, by Application, by Drugs Type and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Modified Release Formulation companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
AbbVie
Novartis
Recipharm
Alkermes
Bristol‑Myers Squibb
Boehringer Ingelheim
Bayer
SPH
Novo Nordisk
Sanofi-Aventis
Eli Lilly
Tonghua Dongbao
United Laboratory
Biocon
Torrent Pharma
Amphastar
Ganlee
GSK
Segment by Type
Tablet
Injection
Segment by Drugs Type
Brand Drugs
Generic Drugs
Segment by Disease
Central Nervous System Diseases
Cardiovascular Diseases
Diabetes
Cancer
Chronic Pain
Other
Segment by Application
Hospital
Retail Pharmacy
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Drugs Type etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Modified Release Formulation company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Modified Release Formulation Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Tablet
1.2.3 Injection
1.3 Market by Drugs Type
1.3.1 Global Modified Release Formulation Market Size Growth Rate by Drugs Type: 2020 VS 2024 VS 2031
1.3.2 Brand Drugs
1.3.3 Generic Drugs
1.4 Market by Disease
1.4.1 Global Modified Release Formulation Market Size Growth Rate by Disease: 2020 VS 2024 VS 2031
1.4.2 Central Nervous System Diseases
1.4.3 Cardiovascular Diseases
1.4.4 Diabetes
1.4.5 Cancer
1.4.6 Chronic Pain
1.4.7 Other
1.5 Market by Application
1.5.1 Global Modified Release Formulation Market Growth by Application: 2020 VS 2024 VS 2031
1.5.2 Hospital
1.5.3 Retail Pharmacy
1.5.4 Other
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Modified Release Formulation Market Perspective (2020-2031)
2.2 Global Modified Release Formulation Growth Trends by Region
2.2.1 Global Modified Release Formulation Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Modified Release Formulation Historic Market Size by Region (2020-2025)
2.2.3 Modified Release Formulation Forecasted Market Size by Region (2026-2031)
2.3 Modified Release Formulation Market Dynamics
2.3.1 Modified Release Formulation Industry Trends
2.3.2 Modified Release Formulation Market Drivers
2.3.3 Modified Release Formulation Market Challenges
2.3.4 Modified Release Formulation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Modified Release Formulation Players by Revenue
3.1.1 Global Top Modified Release Formulation Players by Revenue (2020-2025)
3.1.2 Global Modified Release Formulation Revenue Market Share by Players (2020-2025)
3.2 Global Top Modified Release Formulation Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Modified Release Formulation Revenue
3.4 Global Modified Release Formulation Market Concentration Ratio
3.4.1 Global Modified Release Formulation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Modified Release Formulation Revenue in 2024
3.5 Global Key Players of Modified Release Formulation Head office and Area Served
3.6 Global Key Players of Modified Release Formulation, Product and Application
3.7 Global Key Players of Modified Release Formulation, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Modified Release Formulation Breakdown Data by Type
4.1 Global Modified Release Formulation Historic Market Size by Type (2020-2025)
4.2 Global Modified Release Formulation Forecasted Market Size by Type (2026-2031)
5 Modified Release Formulation Breakdown Data by Application
5.1 Global Modified Release Formulation Historic Market Size by Application (2020-2025)
5.2 Global Modified Release Formulation Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Modified Release Formulation Market Size (2020-2031)
6.2 North America Modified Release Formulation Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Modified Release Formulation Market Size by Country (2020-2025)
6.4 North America Modified Release Formulation Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Modified Release Formulation Market Size (2020-2031)
7.2 Europe Modified Release Formulation Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Modified Release Formulation Market Size by Country (2020-2025)
7.4 Europe Modified Release Formulation Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Modified Release Formulation Market Size (2020-2031)
8.2 Asia-Pacific Modified Release Formulation Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Modified Release Formulation Market Size by Region (2020-2025)
8.4 Asia-Pacific Modified Release Formulation Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Modified Release Formulation Market Size (2020-2031)
9.2 Latin America Modified Release Formulation Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Modified Release Formulation Market Size by Country (2020-2025)
9.4 Latin America Modified Release Formulation Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Modified Release Formulation Market Size (2020-2031)
10.2 Middle East & Africa Modified Release Formulation Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Modified Release Formulation Market Size by Country (2020-2025)
10.4 Middle East & Africa Modified Release Formulation Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Modified Release Formulation Introduction
11.1.4 Pfizer Revenue in Modified Release Formulation Business (2020-2025)
11.1.5 Pfizer Recent Development
11.2 AbbVie
11.2.1 AbbVie Company Details
11.2.2 AbbVie Business Overview
11.2.3 AbbVie Modified Release Formulation Introduction
11.2.4 AbbVie Revenue in Modified Release Formulation Business (2020-2025)
11.2.5 AbbVie Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Modified Release Formulation Introduction
11.3.4 Novartis Revenue in Modified Release Formulation Business (2020-2025)
11.3.5 Novartis Recent Development
11.4 Recipharm
11.4.1 Recipharm Company Details
11.4.2 Recipharm Business Overview
11.4.3 Recipharm Modified Release Formulation Introduction
11.4.4 Recipharm Revenue in Modified Release Formulation Business (2020-2025)
11.4.5 Recipharm Recent Development
11.5 Alkermes
11.5.1 Alkermes Company Details
11.5.2 Alkermes Business Overview
11.5.3 Alkermes Modified Release Formulation Introduction
11.5.4 Alkermes Revenue in Modified Release Formulation Business (2020-2025)
11.5.5 Alkermes Recent Development
11.6 Bristol‑Myers Squibb
11.6.1 Bristol‑Myers Squibb Company Details
11.6.2 Bristol‑Myers Squibb Business Overview
11.6.3 Bristol‑Myers Squibb Modified Release Formulation Introduction
11.6.4 Bristol‑Myers Squibb Revenue in Modified Release Formulation Business (2020-2025)
11.6.5 Bristol‑Myers Squibb Recent Development
11.7 Boehringer Ingelheim
11.7.1 Boehringer Ingelheim Company Details
11.7.2 Boehringer Ingelheim Business Overview
11.7.3 Boehringer Ingelheim Modified Release Formulation Introduction
11.7.4 Boehringer Ingelheim Revenue in Modified Release Formulation Business (2020-2025)
11.7.5 Boehringer Ingelheim Recent Development
11.8 Bayer
11.8.1 Bayer Company Details
11.8.2 Bayer Business Overview
11.8.3 Bayer Modified Release Formulation Introduction
11.8.4 Bayer Revenue in Modified Release Formulation Business (2020-2025)
11.8.5 Bayer Recent Development
11.9 SPH
11.9.1 SPH Company Details
11.9.2 SPH Business Overview
11.9.3 SPH Modified Release Formulation Introduction
11.9.4 SPH Revenue in Modified Release Formulation Business (2020-2025)
11.9.5 SPH Recent Development
11.10 Novo Nordisk
11.10.1 Novo Nordisk Company Details
11.10.2 Novo Nordisk Business Overview
11.10.3 Novo Nordisk Modified Release Formulation Introduction
11.10.4 Novo Nordisk Revenue in Modified Release Formulation Business (2020-2025)
11.10.5 Novo Nordisk Recent Development
11.11 Sanofi-Aventis
11.11.1 Sanofi-Aventis Company Details
11.11.2 Sanofi-Aventis Business Overview
11.11.3 Sanofi-Aventis Modified Release Formulation Introduction
11.11.4 Sanofi-Aventis Revenue in Modified Release Formulation Business (2020-2025)
11.11.5 Sanofi-Aventis Recent Development
11.12 Eli Lilly
11.12.1 Eli Lilly Company Details
11.12.2 Eli Lilly Business Overview
11.12.3 Eli Lilly Modified Release Formulation Introduction
11.12.4 Eli Lilly Revenue in Modified Release Formulation Business (2020-2025)
11.12.5 Eli Lilly Recent Development
11.13 Tonghua Dongbao
11.13.1 Tonghua Dongbao Company Details
11.13.2 Tonghua Dongbao Business Overview
11.13.3 Tonghua Dongbao Modified Release Formulation Introduction
11.13.4 Tonghua Dongbao Revenue in Modified Release Formulation Business (2020-2025)
11.13.5 Tonghua Dongbao Recent Development
11.14 United Laboratory
11.14.1 United Laboratory Company Details
11.14.2 United Laboratory Business Overview
11.14.3 United Laboratory Modified Release Formulation Introduction
11.14.4 United Laboratory Revenue in Modified Release Formulation Business (2020-2025)
11.14.5 United Laboratory Recent Development
11.15 Biocon
11.15.1 Biocon Company Details
11.15.2 Biocon Business Overview
11.15.3 Biocon Modified Release Formulation Introduction
11.15.4 Biocon Revenue in Modified Release Formulation Business (2020-2025)
11.15.5 Biocon Recent Development
11.16 Torrent Pharma
11.16.1 Torrent Pharma Company Details
11.16.2 Torrent Pharma Business Overview
11.16.3 Torrent Pharma Modified Release Formulation Introduction
11.16.4 Torrent Pharma Revenue in Modified Release Formulation Business (2020-2025)
11.16.5 Torrent Pharma Recent Development
11.17 Amphastar
11.17.1 Amphastar Company Details
11.17.2 Amphastar Business Overview
11.17.3 Amphastar Modified Release Formulation Introduction
11.17.4 Amphastar Revenue in Modified Release Formulation Business (2020-2025)
11.17.5 Amphastar Recent Development
11.18 Ganlee
11.18.1 Ganlee Company Details
11.18.2 Ganlee Business Overview
11.18.3 Ganlee Modified Release Formulation Introduction
11.18.4 Ganlee Revenue in Modified Release Formulation Business (2020-2025)
11.18.5 Ganlee Recent Development
11.19 GSK
11.19.1 GSK Company Details
11.19.2 GSK Business Overview
11.19.3 GSK Modified Release Formulation Introduction
11.19.4 GSK Revenue in Modified Release Formulation Business (2020-2025)
11.19.5 GSK Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Modified Release Formulation Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Tablet
1.2.3 Injection
1.3 Market by Drugs Type
1.3.1 Global Modified Release Formulation Market Size Growth Rate by Drugs Type: 2020 VS 2024 VS 2031
1.3.2 Brand Drugs
1.3.3 Generic Drugs
1.4 Market by Disease
1.4.1 Global Modified Release Formulation Market Size Growth Rate by Disease: 2020 VS 2024 VS 2031
1.4.2 Central Nervous System Diseases
1.4.3 Cardiovascular Diseases
1.4.4 Diabetes
1.4.5 Cancer
1.4.6 Chronic Pain
1.4.7 Other
1.5 Market by Application
1.5.1 Global Modified Release Formulation Market Growth by Application: 2020 VS 2024 VS 2031
1.5.2 Hospital
1.5.3 Retail Pharmacy
1.5.4 Other
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Modified Release Formulation Market Perspective (2020-2031)
2.2 Global Modified Release Formulation Growth Trends by Region
2.2.1 Global Modified Release Formulation Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Modified Release Formulation Historic Market Size by Region (2020-2025)
2.2.3 Modified Release Formulation Forecasted Market Size by Region (2026-2031)
2.3 Modified Release Formulation Market Dynamics
2.3.1 Modified Release Formulation Industry Trends
2.3.2 Modified Release Formulation Market Drivers
2.3.3 Modified Release Formulation Market Challenges
2.3.4 Modified Release Formulation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Modified Release Formulation Players by Revenue
3.1.1 Global Top Modified Release Formulation Players by Revenue (2020-2025)
3.1.2 Global Modified Release Formulation Revenue Market Share by Players (2020-2025)
3.2 Global Top Modified Release Formulation Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Modified Release Formulation Revenue
3.4 Global Modified Release Formulation Market Concentration Ratio
3.4.1 Global Modified Release Formulation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Modified Release Formulation Revenue in 2024
3.5 Global Key Players of Modified Release Formulation Head office and Area Served
3.6 Global Key Players of Modified Release Formulation, Product and Application
3.7 Global Key Players of Modified Release Formulation, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Modified Release Formulation Breakdown Data by Type
4.1 Global Modified Release Formulation Historic Market Size by Type (2020-2025)
4.2 Global Modified Release Formulation Forecasted Market Size by Type (2026-2031)
5 Modified Release Formulation Breakdown Data by Application
5.1 Global Modified Release Formulation Historic Market Size by Application (2020-2025)
5.2 Global Modified Release Formulation Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Modified Release Formulation Market Size (2020-2031)
6.2 North America Modified Release Formulation Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Modified Release Formulation Market Size by Country (2020-2025)
6.4 North America Modified Release Formulation Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Modified Release Formulation Market Size (2020-2031)
7.2 Europe Modified Release Formulation Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Modified Release Formulation Market Size by Country (2020-2025)
7.4 Europe Modified Release Formulation Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Modified Release Formulation Market Size (2020-2031)
8.2 Asia-Pacific Modified Release Formulation Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Modified Release Formulation Market Size by Region (2020-2025)
8.4 Asia-Pacific Modified Release Formulation Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Modified Release Formulation Market Size (2020-2031)
9.2 Latin America Modified Release Formulation Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Modified Release Formulation Market Size by Country (2020-2025)
9.4 Latin America Modified Release Formulation Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Modified Release Formulation Market Size (2020-2031)
10.2 Middle East & Africa Modified Release Formulation Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Modified Release Formulation Market Size by Country (2020-2025)
10.4 Middle East & Africa Modified Release Formulation Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Modified Release Formulation Introduction
11.1.4 Pfizer Revenue in Modified Release Formulation Business (2020-2025)
11.1.5 Pfizer Recent Development
11.2 AbbVie
11.2.1 AbbVie Company Details
11.2.2 AbbVie Business Overview
11.2.3 AbbVie Modified Release Formulation Introduction
11.2.4 AbbVie Revenue in Modified Release Formulation Business (2020-2025)
11.2.5 AbbVie Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Modified Release Formulation Introduction
11.3.4 Novartis Revenue in Modified Release Formulation Business (2020-2025)
11.3.5 Novartis Recent Development
11.4 Recipharm
11.4.1 Recipharm Company Details
11.4.2 Recipharm Business Overview
11.4.3 Recipharm Modified Release Formulation Introduction
11.4.4 Recipharm Revenue in Modified Release Formulation Business (2020-2025)
11.4.5 Recipharm Recent Development
11.5 Alkermes
11.5.1 Alkermes Company Details
11.5.2 Alkermes Business Overview
11.5.3 Alkermes Modified Release Formulation Introduction
11.5.4 Alkermes Revenue in Modified Release Formulation Business (2020-2025)
11.5.5 Alkermes Recent Development
11.6 Bristol‑Myers Squibb
11.6.1 Bristol‑Myers Squibb Company Details
11.6.2 Bristol‑Myers Squibb Business Overview
11.6.3 Bristol‑Myers Squibb Modified Release Formulation Introduction
11.6.4 Bristol‑Myers Squibb Revenue in Modified Release Formulation Business (2020-2025)
11.6.5 Bristol‑Myers Squibb Recent Development
11.7 Boehringer Ingelheim
11.7.1 Boehringer Ingelheim Company Details
11.7.2 Boehringer Ingelheim Business Overview
11.7.3 Boehringer Ingelheim Modified Release Formulation Introduction
11.7.4 Boehringer Ingelheim Revenue in Modified Release Formulation Business (2020-2025)
11.7.5 Boehringer Ingelheim Recent Development
11.8 Bayer
11.8.1 Bayer Company Details
11.8.2 Bayer Business Overview
11.8.3 Bayer Modified Release Formulation Introduction
11.8.4 Bayer Revenue in Modified Release Formulation Business (2020-2025)
11.8.5 Bayer Recent Development
11.9 SPH
11.9.1 SPH Company Details
11.9.2 SPH Business Overview
11.9.3 SPH Modified Release Formulation Introduction
11.9.4 SPH Revenue in Modified Release Formulation Business (2020-2025)
11.9.5 SPH Recent Development
11.10 Novo Nordisk
11.10.1 Novo Nordisk Company Details
11.10.2 Novo Nordisk Business Overview
11.10.3 Novo Nordisk Modified Release Formulation Introduction
11.10.4 Novo Nordisk Revenue in Modified Release Formulation Business (2020-2025)
11.10.5 Novo Nordisk Recent Development
11.11 Sanofi-Aventis
11.11.1 Sanofi-Aventis Company Details
11.11.2 Sanofi-Aventis Business Overview
11.11.3 Sanofi-Aventis Modified Release Formulation Introduction
11.11.4 Sanofi-Aventis Revenue in Modified Release Formulation Business (2020-2025)
11.11.5 Sanofi-Aventis Recent Development
11.12 Eli Lilly
11.12.1 Eli Lilly Company Details
11.12.2 Eli Lilly Business Overview
11.12.3 Eli Lilly Modified Release Formulation Introduction
11.12.4 Eli Lilly Revenue in Modified Release Formulation Business (2020-2025)
11.12.5 Eli Lilly Recent Development
11.13 Tonghua Dongbao
11.13.1 Tonghua Dongbao Company Details
11.13.2 Tonghua Dongbao Business Overview
11.13.3 Tonghua Dongbao Modified Release Formulation Introduction
11.13.4 Tonghua Dongbao Revenue in Modified Release Formulation Business (2020-2025)
11.13.5 Tonghua Dongbao Recent Development
11.14 United Laboratory
11.14.1 United Laboratory Company Details
11.14.2 United Laboratory Business Overview
11.14.3 United Laboratory Modified Release Formulation Introduction
11.14.4 United Laboratory Revenue in Modified Release Formulation Business (2020-2025)
11.14.5 United Laboratory Recent Development
11.15 Biocon
11.15.1 Biocon Company Details
11.15.2 Biocon Business Overview
11.15.3 Biocon Modified Release Formulation Introduction
11.15.4 Biocon Revenue in Modified Release Formulation Business (2020-2025)
11.15.5 Biocon Recent Development
11.16 Torrent Pharma
11.16.1 Torrent Pharma Company Details
11.16.2 Torrent Pharma Business Overview
11.16.3 Torrent Pharma Modified Release Formulation Introduction
11.16.4 Torrent Pharma Revenue in Modified Release Formulation Business (2020-2025)
11.16.5 Torrent Pharma Recent Development
11.17 Amphastar
11.17.1 Amphastar Company Details
11.17.2 Amphastar Business Overview
11.17.3 Amphastar Modified Release Formulation Introduction
11.17.4 Amphastar Revenue in Modified Release Formulation Business (2020-2025)
11.17.5 Amphastar Recent Development
11.18 Ganlee
11.18.1 Ganlee Company Details
11.18.2 Ganlee Business Overview
11.18.3 Ganlee Modified Release Formulation Introduction
11.18.4 Ganlee Revenue in Modified Release Formulation Business (2020-2025)
11.18.5 Ganlee Recent Development
11.19 GSK
11.19.1 GSK Company Details
11.19.2 GSK Business Overview
11.19.3 GSK Modified Release Formulation Introduction
11.19.4 GSK Revenue in Modified Release Formulation Business (2020-2025)
11.19.5 GSK Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Modified Release Formulation Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Tablet
Table 3. Key Players of Injection
Table 4. Global Modified Release Formulation Market Size Growth Rate by Drugs Type (US$ Million): 2020 VS 2024 VS 2031
Table 5. Key Players of Brand Drugs
Table 6. Key Players of Generic Drugs
Table 7. Global Modified Release Formulation Market Size Growth Rate by Disease (US$ Million): 2020 VS 2024 VS 2031
Table 8. Key Players of Central Nervous System Diseases
Table 9. Key Players of Cardiovascular Diseases
Table 10. Key Players of Diabetes
Table 11. Key Players of Cancer
Table 12. Key Players of Chronic Pain
Table 13. Key Players of Other
Table 14. Global Modified Release Formulation Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 15. Global Modified Release Formulation Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 16. Global Modified Release Formulation Market Size by Region (2020-2025) & (US$ Million)
Table 17. Global Modified Release Formulation Market Share by Region (2020-2025)
Table 18. Global Modified Release Formulation Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 19. Global Modified Release Formulation Market Share by Region (2026-2031)
Table 20. Modified Release Formulation Market Trends
Table 21. Modified Release Formulation Market Drivers
Table 22. Modified Release Formulation Market Challenges
Table 23. Modified Release Formulation Market Restraints
Table 24. Global Modified Release Formulation Revenue by Players (2020-2025) & (US$ Million)
Table 25. Global Modified Release Formulation Market Share by Players (2020-2025)
Table 26. Global Top Modified Release Formulation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Modified Release Formulation as of 2024)
Table 27. Ranking of Global Top Modified Release Formulation Companies by Revenue (US$ Million) in 2024
Table 28. Global 5 Largest Players Market Share by Modified Release Formulation Revenue (CR5 and HHI) & (2020-2025)
Table 29. Global Key Players of Modified Release Formulation, Headquarters and Area Served
Table 30. Global Key Players of Modified Release Formulation, Product and Application
Table 31. Global Key Players of Modified Release Formulation, Date of Enter into This Industry
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Modified Release Formulation Market Size by Type (2020-2025) & (US$ Million)
Table 34. Global Modified Release Formulation Revenue Market Share by Type (2020-2025)
Table 35. Global Modified Release Formulation Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 36. Global Modified Release Formulation Revenue Market Share by Type (2026-2031)
Table 37. Global Modified Release Formulation Market Size by Application (2020-2025) & (US$ Million)
Table 38. Global Modified Release Formulation Revenue Market Share by Application (2020-2025)
Table 39. Global Modified Release Formulation Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 40. Global Modified Release Formulation Revenue Market Share by Application (2026-2031)
Table 41. North America Modified Release Formulation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. North America Modified Release Formulation Market Size by Country (2020-2025) & (US$ Million)
Table 43. North America Modified Release Formulation Market Size by Country (2026-2031) & (US$ Million)
Table 44. Europe Modified Release Formulation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Europe Modified Release Formulation Market Size by Country (2020-2025) & (US$ Million)
Table 46. Europe Modified Release Formulation Market Size by Country (2026-2031) & (US$ Million)
Table 47. Asia-Pacific Modified Release Formulation Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 48. Asia-Pacific Modified Release Formulation Market Size by Region (2020-2025) & (US$ Million)
Table 49. Asia-Pacific Modified Release Formulation Market Size by Region (2026-2031) & (US$ Million)
Table 50. Latin America Modified Release Formulation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 51. Latin America Modified Release Formulation Market Size by Country (2020-2025) & (US$ Million)
Table 52. Latin America Modified Release Formulation Market Size by Country (2026-2031) & (US$ Million)
Table 53. Middle East & Africa Modified Release Formulation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 54. Middle East & Africa Modified Release Formulation Market Size by Country (2020-2025) & (US$ Million)
Table 55. Middle East & Africa Modified Release Formulation Market Size by Country (2026-2031) & (US$ Million)
Table 56. Pfizer Company Details
Table 57. Pfizer Business Overview
Table 58. Pfizer Modified Release Formulation Product
Table 59. Pfizer Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)
Table 60. Pfizer Recent Development
Table 61. AbbVie Company Details
Table 62. AbbVie Business Overview
Table 63. AbbVie Modified Release Formulation Product
Table 64. AbbVie Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)
Table 65. AbbVie Recent Development
Table 66. Novartis Company Details
Table 67. Novartis Business Overview
Table 68. Novartis Modified Release Formulation Product
Table 69. Novartis Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)
Table 70. Novartis Recent Development
Table 71. Recipharm Company Details
Table 72. Recipharm Business Overview
Table 73. Recipharm Modified Release Formulation Product
Table 74. Recipharm Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)
Table 75. Recipharm Recent Development
Table 76. Alkermes Company Details
Table 77. Alkermes Business Overview
Table 78. Alkermes Modified Release Formulation Product
Table 79. Alkermes Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)
Table 80. Alkermes Recent Development
Table 81. Bristol‑Myers Squibb Company Details
Table 82. Bristol‑Myers Squibb Business Overview
Table 83. Bristol‑Myers Squibb Modified Release Formulation Product
Table 84. Bristol‑Myers Squibb Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)
Table 85. Bristol‑Myers Squibb Recent Development
Table 86. Boehringer Ingelheim Company Details
Table 87. Boehringer Ingelheim Business Overview
Table 88. Boehringer Ingelheim Modified Release Formulation Product
Table 89. Boehringer Ingelheim Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)
Table 90. Boehringer Ingelheim Recent Development
Table 91. Bayer Company Details
Table 92. Bayer Business Overview
Table 93. Bayer Modified Release Formulation Product
Table 94. Bayer Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)
Table 95. Bayer Recent Development
Table 96. SPH Company Details
Table 97. SPH Business Overview
Table 98. SPH Modified Release Formulation Product
Table 99. SPH Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)
Table 100. SPH Recent Development
Table 101. Novo Nordisk Company Details
Table 102. Novo Nordisk Business Overview
Table 103. Novo Nordisk Modified Release Formulation Product
Table 104. Novo Nordisk Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)
Table 105. Novo Nordisk Recent Development
Table 106. Sanofi-Aventis Company Details
Table 107. Sanofi-Aventis Business Overview
Table 108. Sanofi-Aventis Modified Release Formulation Product
Table 109. Sanofi-Aventis Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)
Table 110. Sanofi-Aventis Recent Development
Table 111. Eli Lilly Company Details
Table 112. Eli Lilly Business Overview
Table 113. Eli Lilly Modified Release Formulation Product
Table 114. Eli Lilly Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)
Table 115. Eli Lilly Recent Development
Table 116. Tonghua Dongbao Company Details
Table 117. Tonghua Dongbao Business Overview
Table 118. Tonghua Dongbao Modified Release Formulation Product
Table 119. Tonghua Dongbao Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)
Table 120. Tonghua Dongbao Recent Development
Table 121. United Laboratory Company Details
Table 122. United Laboratory Business Overview
Table 123. United Laboratory Modified Release Formulation Product
Table 124. United Laboratory Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)
Table 125. United Laboratory Recent Development
Table 126. Biocon Company Details
Table 127. Biocon Business Overview
Table 128. Biocon Modified Release Formulation Product
Table 129. Biocon Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)
Table 130. Biocon Recent Development
Table 131. Torrent Pharma Company Details
Table 132. Torrent Pharma Business Overview
Table 133. Torrent Pharma Modified Release Formulation Product
Table 134. Torrent Pharma Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)
Table 135. Torrent Pharma Recent Development
Table 136. Amphastar Company Details
Table 137. Amphastar Business Overview
Table 138. Amphastar Modified Release Formulation Product
Table 139. Amphastar Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)
Table 140. Amphastar Recent Development
Table 141. Ganlee Company Details
Table 142. Ganlee Business Overview
Table 143. Ganlee Modified Release Formulation Product
Table 144. Ganlee Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)
Table 145. Ganlee Recent Development
Table 146. GSK Company Details
Table 147. GSK Business Overview
Table 148. GSK Modified Release Formulation Product
Table 149. GSK Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)
Table 150. GSK Recent Development
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
Table 154. Authors List of This Report
List of Figures
Figure 1. Modified Release Formulation Picture
Figure 2. Global Modified Release Formulation Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Modified Release Formulation Market Share by Type: 2024 VS 2031
Figure 4. Tablet Features
Figure 5. Injection Features
Figure 6. Global Modified Release Formulation Market Size Comparison by Drugs Type (2020-2031) & (US$ Million)
Figure 7. Brand Drugs Features
Figure 8. Generic Drugs Features
Figure 9. Global Modified Release Formulation Market Size Comparison by Disease (2020-2031) & (US$ Million)
Figure 10. Central Nervous System Diseases Features
Figure 11. Cardiovascular Diseases Features
Figure 12. Diabetes Features
Figure 13. Cancer Features
Figure 14. Chronic Pain Features
Figure 15. Other Features
Figure 16. Global Modified Release Formulation Market Size by Application (2020-2031) & (US$ Million)
Figure 17. Global Modified Release Formulation Market Share by Application: 2024 VS 2031
Figure 18. Hospital Case Studies
Figure 19. Retail Pharmacy Case Studies
Figure 20. Other Case Studies
Figure 21. Modified Release Formulation Report Years Considered
Figure 22. Global Modified Release Formulation Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 23. Global Modified Release Formulation Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 24. Global Modified Release Formulation Market Share by Region: 2024 VS 2031
Figure 25. Global Modified Release Formulation Market Share by Players in 2024
Figure 26. Global Modified Release Formulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 27. The Top 10 and 5 Players Market Share by Modified Release Formulation Revenue in 2024
Figure 28. North America Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. North America Modified Release Formulation Market Share by Country (2020-2031)
Figure 30. United States Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Canada Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Europe Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Europe Modified Release Formulation Market Share by Country (2020-2031)
Figure 34. Germany Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. France Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. U.K. Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Italy Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Russia Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Ireland Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Asia-Pacific Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Asia-Pacific Modified Release Formulation Market Share by Region (2020-2031)
Figure 42. China Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Japan Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. South Korea Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Southeast Asia Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. India Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Australia & New Zealand Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Latin America Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Latin America Modified Release Formulation Market Share by Country (2020-2031)
Figure 50. Mexico Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Brazil Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Middle East & Africa Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Middle East & Africa Modified Release Formulation Market Share by Country (2020-2031)
Figure 54. Israel Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 55. Saudi Arabia Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 56. UAE Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 57. Pfizer Revenue Growth Rate in Modified Release Formulation Business (2020-2025)
Figure 58. AbbVie Revenue Growth Rate in Modified Release Formulation Business (2020-2025)
Figure 59. Novartis Revenue Growth Rate in Modified Release Formulation Business (2020-2025)
Figure 60. Recipharm Revenue Growth Rate in Modified Release Formulation Business (2020-2025)
Figure 61. Alkermes Revenue Growth Rate in Modified Release Formulation Business (2020-2025)
Figure 62. Bristol‑Myers Squibb Revenue Growth Rate in Modified Release Formulation Business (2020-2025)
Figure 63. Boehringer Ingelheim Revenue Growth Rate in Modified Release Formulation Business (2020-2025)
Figure 64. Bayer Revenue Growth Rate in Modified Release Formulation Business (2020-2025)
Figure 65. SPH Revenue Growth Rate in Modified Release Formulation Business (2020-2025)
Figure 66. Novo Nordisk Revenue Growth Rate in Modified Release Formulation Business (2020-2025)
Figure 67. Sanofi-Aventis Revenue Growth Rate in Modified Release Formulation Business (2020-2025)
Figure 68. Eli Lilly Revenue Growth Rate in Modified Release Formulation Business (2020-2025)
Figure 69. Tonghua Dongbao Revenue Growth Rate in Modified Release Formulation Business (2020-2025)
Figure 70. United Laboratory Revenue Growth Rate in Modified Release Formulation Business (2020-2025)
Figure 71. Biocon Revenue Growth Rate in Modified Release Formulation Business (2020-2025)
Figure 72. Torrent Pharma Revenue Growth Rate in Modified Release Formulation Business (2020-2025)
Figure 73. Amphastar Revenue Growth Rate in Modified Release Formulation Business (2020-2025)
Figure 74. Ganlee Revenue Growth Rate in Modified Release Formulation Business (2020-2025)
Figure 75. GSK Revenue Growth Rate in Modified Release Formulation Business (2020-2025)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
Table 1. Global Modified Release Formulation Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Tablet
Table 3. Key Players of Injection
Table 4. Global Modified Release Formulation Market Size Growth Rate by Drugs Type (US$ Million): 2020 VS 2024 VS 2031
Table 5. Key Players of Brand Drugs
Table 6. Key Players of Generic Drugs
Table 7. Global Modified Release Formulation Market Size Growth Rate by Disease (US$ Million): 2020 VS 2024 VS 2031
Table 8. Key Players of Central Nervous System Diseases
Table 9. Key Players of Cardiovascular Diseases
Table 10. Key Players of Diabetes
Table 11. Key Players of Cancer
Table 12. Key Players of Chronic Pain
Table 13. Key Players of Other
Table 14. Global Modified Release Formulation Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 15. Global Modified Release Formulation Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 16. Global Modified Release Formulation Market Size by Region (2020-2025) & (US$ Million)
Table 17. Global Modified Release Formulation Market Share by Region (2020-2025)
Table 18. Global Modified Release Formulation Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 19. Global Modified Release Formulation Market Share by Region (2026-2031)
Table 20. Modified Release Formulation Market Trends
Table 21. Modified Release Formulation Market Drivers
Table 22. Modified Release Formulation Market Challenges
Table 23. Modified Release Formulation Market Restraints
Table 24. Global Modified Release Formulation Revenue by Players (2020-2025) & (US$ Million)
Table 25. Global Modified Release Formulation Market Share by Players (2020-2025)
Table 26. Global Top Modified Release Formulation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Modified Release Formulation as of 2024)
Table 27. Ranking of Global Top Modified Release Formulation Companies by Revenue (US$ Million) in 2024
Table 28. Global 5 Largest Players Market Share by Modified Release Formulation Revenue (CR5 and HHI) & (2020-2025)
Table 29. Global Key Players of Modified Release Formulation, Headquarters and Area Served
Table 30. Global Key Players of Modified Release Formulation, Product and Application
Table 31. Global Key Players of Modified Release Formulation, Date of Enter into This Industry
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Modified Release Formulation Market Size by Type (2020-2025) & (US$ Million)
Table 34. Global Modified Release Formulation Revenue Market Share by Type (2020-2025)
Table 35. Global Modified Release Formulation Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 36. Global Modified Release Formulation Revenue Market Share by Type (2026-2031)
Table 37. Global Modified Release Formulation Market Size by Application (2020-2025) & (US$ Million)
Table 38. Global Modified Release Formulation Revenue Market Share by Application (2020-2025)
Table 39. Global Modified Release Formulation Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 40. Global Modified Release Formulation Revenue Market Share by Application (2026-2031)
Table 41. North America Modified Release Formulation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. North America Modified Release Formulation Market Size by Country (2020-2025) & (US$ Million)
Table 43. North America Modified Release Formulation Market Size by Country (2026-2031) & (US$ Million)
Table 44. Europe Modified Release Formulation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Europe Modified Release Formulation Market Size by Country (2020-2025) & (US$ Million)
Table 46. Europe Modified Release Formulation Market Size by Country (2026-2031) & (US$ Million)
Table 47. Asia-Pacific Modified Release Formulation Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 48. Asia-Pacific Modified Release Formulation Market Size by Region (2020-2025) & (US$ Million)
Table 49. Asia-Pacific Modified Release Formulation Market Size by Region (2026-2031) & (US$ Million)
Table 50. Latin America Modified Release Formulation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 51. Latin America Modified Release Formulation Market Size by Country (2020-2025) & (US$ Million)
Table 52. Latin America Modified Release Formulation Market Size by Country (2026-2031) & (US$ Million)
Table 53. Middle East & Africa Modified Release Formulation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 54. Middle East & Africa Modified Release Formulation Market Size by Country (2020-2025) & (US$ Million)
Table 55. Middle East & Africa Modified Release Formulation Market Size by Country (2026-2031) & (US$ Million)
Table 56. Pfizer Company Details
Table 57. Pfizer Business Overview
Table 58. Pfizer Modified Release Formulation Product
Table 59. Pfizer Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)
Table 60. Pfizer Recent Development
Table 61. AbbVie Company Details
Table 62. AbbVie Business Overview
Table 63. AbbVie Modified Release Formulation Product
Table 64. AbbVie Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)
Table 65. AbbVie Recent Development
Table 66. Novartis Company Details
Table 67. Novartis Business Overview
Table 68. Novartis Modified Release Formulation Product
Table 69. Novartis Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)
Table 70. Novartis Recent Development
Table 71. Recipharm Company Details
Table 72. Recipharm Business Overview
Table 73. Recipharm Modified Release Formulation Product
Table 74. Recipharm Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)
Table 75. Recipharm Recent Development
Table 76. Alkermes Company Details
Table 77. Alkermes Business Overview
Table 78. Alkermes Modified Release Formulation Product
Table 79. Alkermes Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)
Table 80. Alkermes Recent Development
Table 81. Bristol‑Myers Squibb Company Details
Table 82. Bristol‑Myers Squibb Business Overview
Table 83. Bristol‑Myers Squibb Modified Release Formulation Product
Table 84. Bristol‑Myers Squibb Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)
Table 85. Bristol‑Myers Squibb Recent Development
Table 86. Boehringer Ingelheim Company Details
Table 87. Boehringer Ingelheim Business Overview
Table 88. Boehringer Ingelheim Modified Release Formulation Product
Table 89. Boehringer Ingelheim Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)
Table 90. Boehringer Ingelheim Recent Development
Table 91. Bayer Company Details
Table 92. Bayer Business Overview
Table 93. Bayer Modified Release Formulation Product
Table 94. Bayer Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)
Table 95. Bayer Recent Development
Table 96. SPH Company Details
Table 97. SPH Business Overview
Table 98. SPH Modified Release Formulation Product
Table 99. SPH Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)
Table 100. SPH Recent Development
Table 101. Novo Nordisk Company Details
Table 102. Novo Nordisk Business Overview
Table 103. Novo Nordisk Modified Release Formulation Product
Table 104. Novo Nordisk Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)
Table 105. Novo Nordisk Recent Development
Table 106. Sanofi-Aventis Company Details
Table 107. Sanofi-Aventis Business Overview
Table 108. Sanofi-Aventis Modified Release Formulation Product
Table 109. Sanofi-Aventis Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)
Table 110. Sanofi-Aventis Recent Development
Table 111. Eli Lilly Company Details
Table 112. Eli Lilly Business Overview
Table 113. Eli Lilly Modified Release Formulation Product
Table 114. Eli Lilly Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)
Table 115. Eli Lilly Recent Development
Table 116. Tonghua Dongbao Company Details
Table 117. Tonghua Dongbao Business Overview
Table 118. Tonghua Dongbao Modified Release Formulation Product
Table 119. Tonghua Dongbao Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)
Table 120. Tonghua Dongbao Recent Development
Table 121. United Laboratory Company Details
Table 122. United Laboratory Business Overview
Table 123. United Laboratory Modified Release Formulation Product
Table 124. United Laboratory Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)
Table 125. United Laboratory Recent Development
Table 126. Biocon Company Details
Table 127. Biocon Business Overview
Table 128. Biocon Modified Release Formulation Product
Table 129. Biocon Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)
Table 130. Biocon Recent Development
Table 131. Torrent Pharma Company Details
Table 132. Torrent Pharma Business Overview
Table 133. Torrent Pharma Modified Release Formulation Product
Table 134. Torrent Pharma Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)
Table 135. Torrent Pharma Recent Development
Table 136. Amphastar Company Details
Table 137. Amphastar Business Overview
Table 138. Amphastar Modified Release Formulation Product
Table 139. Amphastar Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)
Table 140. Amphastar Recent Development
Table 141. Ganlee Company Details
Table 142. Ganlee Business Overview
Table 143. Ganlee Modified Release Formulation Product
Table 144. Ganlee Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)
Table 145. Ganlee Recent Development
Table 146. GSK Company Details
Table 147. GSK Business Overview
Table 148. GSK Modified Release Formulation Product
Table 149. GSK Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)
Table 150. GSK Recent Development
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
Table 154. Authors List of This Report
List of Figures
Figure 1. Modified Release Formulation Picture
Figure 2. Global Modified Release Formulation Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Modified Release Formulation Market Share by Type: 2024 VS 2031
Figure 4. Tablet Features
Figure 5. Injection Features
Figure 6. Global Modified Release Formulation Market Size Comparison by Drugs Type (2020-2031) & (US$ Million)
Figure 7. Brand Drugs Features
Figure 8. Generic Drugs Features
Figure 9. Global Modified Release Formulation Market Size Comparison by Disease (2020-2031) & (US$ Million)
Figure 10. Central Nervous System Diseases Features
Figure 11. Cardiovascular Diseases Features
Figure 12. Diabetes Features
Figure 13. Cancer Features
Figure 14. Chronic Pain Features
Figure 15. Other Features
Figure 16. Global Modified Release Formulation Market Size by Application (2020-2031) & (US$ Million)
Figure 17. Global Modified Release Formulation Market Share by Application: 2024 VS 2031
Figure 18. Hospital Case Studies
Figure 19. Retail Pharmacy Case Studies
Figure 20. Other Case Studies
Figure 21. Modified Release Formulation Report Years Considered
Figure 22. Global Modified Release Formulation Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 23. Global Modified Release Formulation Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 24. Global Modified Release Formulation Market Share by Region: 2024 VS 2031
Figure 25. Global Modified Release Formulation Market Share by Players in 2024
Figure 26. Global Modified Release Formulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 27. The Top 10 and 5 Players Market Share by Modified Release Formulation Revenue in 2024
Figure 28. North America Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. North America Modified Release Formulation Market Share by Country (2020-2031)
Figure 30. United States Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Canada Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Europe Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Europe Modified Release Formulation Market Share by Country (2020-2031)
Figure 34. Germany Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. France Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. U.K. Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Italy Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Russia Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Ireland Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Asia-Pacific Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Asia-Pacific Modified Release Formulation Market Share by Region (2020-2031)
Figure 42. China Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Japan Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. South Korea Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Southeast Asia Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. India Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Australia & New Zealand Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Latin America Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Latin America Modified Release Formulation Market Share by Country (2020-2031)
Figure 50. Mexico Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Brazil Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Middle East & Africa Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Middle East & Africa Modified Release Formulation Market Share by Country (2020-2031)
Figure 54. Israel Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 55. Saudi Arabia Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 56. UAE Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 57. Pfizer Revenue Growth Rate in Modified Release Formulation Business (2020-2025)
Figure 58. AbbVie Revenue Growth Rate in Modified Release Formulation Business (2020-2025)
Figure 59. Novartis Revenue Growth Rate in Modified Release Formulation Business (2020-2025)
Figure 60. Recipharm Revenue Growth Rate in Modified Release Formulation Business (2020-2025)
Figure 61. Alkermes Revenue Growth Rate in Modified Release Formulation Business (2020-2025)
Figure 62. Bristol‑Myers Squibb Revenue Growth Rate in Modified Release Formulation Business (2020-2025)
Figure 63. Boehringer Ingelheim Revenue Growth Rate in Modified Release Formulation Business (2020-2025)
Figure 64. Bayer Revenue Growth Rate in Modified Release Formulation Business (2020-2025)
Figure 65. SPH Revenue Growth Rate in Modified Release Formulation Business (2020-2025)
Figure 66. Novo Nordisk Revenue Growth Rate in Modified Release Formulation Business (2020-2025)
Figure 67. Sanofi-Aventis Revenue Growth Rate in Modified Release Formulation Business (2020-2025)
Figure 68. Eli Lilly Revenue Growth Rate in Modified Release Formulation Business (2020-2025)
Figure 69. Tonghua Dongbao Revenue Growth Rate in Modified Release Formulation Business (2020-2025)
Figure 70. United Laboratory Revenue Growth Rate in Modified Release Formulation Business (2020-2025)
Figure 71. Biocon Revenue Growth Rate in Modified Release Formulation Business (2020-2025)
Figure 72. Torrent Pharma Revenue Growth Rate in Modified Release Formulation Business (2020-2025)
Figure 73. Amphastar Revenue Growth Rate in Modified Release Formulation Business (2020-2025)
Figure 74. Ganlee Revenue Growth Rate in Modified Release Formulation Business (2020-2025)
Figure 75. GSK Revenue Growth Rate in Modified Release Formulation Business (2020-2025)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232